Related Experiment Video
Updated: May 23, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Identification of NIBAN2-Regulated RUNX2 Alternative Splicing Presents Novel Strategies for Antagonizing Osteoporosis
Sheng Zhang1, Zhiqiang Yang1, Yuanlong Xie1
1Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, No. 163 Donghu Road, Wuhan, Hubei, 430071, P. R. China.
Abstract:
Osteoporosis is characterized by excessive bone resorption and/or defects in bone formation. Identification of factors promoting osteoblast differentiation may provide potential targets for osteoporosis therapy. Through integral analyses of multiple datasets, NIBAN2 is found to be tightly associated with bone formation and osteoporosis. Indeed, NIBAN2 promotes osteoblast differentiation, and conditional Niban2 knockout in osteoblasts caused bone loss and insufficient mineralization. Mechanistically, NIBAN2 interacts with the HNRNPU-cored spliceosome complex and alters its components to regulate the alternative splicing of RUNX2, which ultimately cause an increase in functional RUNX2 (nuclear localization sequence complete) but a decrease in dysfunctional RUNX2 (exon 6 exclusive) to reinforce osteoblast differentiation. Most importantly, NIBAN2 expression level negatively correlates with RUNX2 spliced isoforms and bone loss in osteoporosis patients. NIBAN2 overexpression rescues bone loss in ovariectomized mice. Thus, this research identifies NIBAN2-regulated RUNX2 alternative splicing as a potential mechanism of osteoblast differentiation that may present strategies for antagonizing osteoporosis.
Insights
New research reveals NIBAN2 promotes osteoblast differentiation by regulating RUNX2 alternative splicing, offering a potential therapeutic strategy for osteoporosis and bone loss. This finding could lead to novel treatments for bone diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Orthopedics
Background:
- Osteoporosis involves imbalanced bone resorption and formation.
- Identifying factors that enhance osteoblast differentiation is crucial for osteoporosis treatment.
Purpose of the Study:
- To investigate the role of NIBAN2 in bone formation and osteoporosis.
- To elucidate the molecular mechanism by which NIBAN2 influences osteoblast differentiation.
Main Methods:
- Analysis of multiple biological datasets.
- Conditional knockout of Niban2 in osteoblasts.
- Investigation of NIBAN2 interaction with the spliceosome complex.
- Assessment of RUNX2 alternative splicing.
- Evaluation of bone parameters in mouse models and human patients.
Main Results:
- NIBAN2 promotes osteoblast differentiation and bone mineralization.
- Niban2 deficiency leads to bone loss and impaired mineralization.
- NIBAN2 regulates RUNX2 alternative splicing, favoring functional isoforms.
- NIBAN2 expression inversely correlates with bone loss and RUNX2 spliced isoforms in osteoporosis patients.
- NIBAN2 overexpression ameliorates bone loss in ovariectomized mice.
Conclusions:
- NIBAN2 plays a critical role in osteoblast differentiation through RUNX2 alternative splicing.
- The NIBAN2-RUNX2 splicing axis represents a potential therapeutic target for osteoporosis.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
The Nucleolus

